HomeInsightsResults

Oxygenta Pharmaceutical Ltd Quarterly Result

Oxygenta Pharmaceutical Ltd Quarterly Result

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

43.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Net Profit

₹ -2.85

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Oxygenta Pharmaceutical Ltd for the Sep '24 is ₹ 14.75 crore as compare to the Jun '24 revenue of ₹ 12.64 crore. This represent the growth of 16.693035%.
  • The ebitda of Oxygenta Pharmaceutical Ltd for the Sep '24 is ₹ -1.42 crore as compare to the Jun '24 ebitda of ₹ -1.76 crore. This represent the decline of -19.318184%.
  • The net profit of Oxygenta Pharmaceutical Ltd for the Sep '24 is ₹ -2.85 crore as compare to the Jun '24 net profit of ₹ -1.36 crore. This represent the growth of 109.55881%.

Results Analysis

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202473.1
21 Nov 202470.85
19 Nov 202474.22
18 Nov 202477.87
14 Nov 202481.96
13 Nov 202483.63
12 Nov 202485.33
11 Nov 202487.07
08 Nov 202488.84
07 Nov 202490.65

Historical Revenue of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical EBITDA of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Net Profit of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Oxygenta Pharmaceutical Ltd News Hub

News

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

11 Nov 202411:06

News

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the compan...

Read more

18 Sep 202410:58

News

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14...

Read more

12 Aug 202414:50

News

Oxygenta Pharmaceutical to announce Quarterly Result

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 30...

Read more

28 May 202415:31

News

Oxygenta Pharmaceutical EGM scheduled

Oxygenta Pharmaceutical announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

09 Apr 202417:34

News

Oxygenta Pharmaceutical to convene board meeting

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 8 ...

Read more

04 Apr 202409:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Oxygenta Pharmaceutical Ltd Quarterly Result

What is the EPS of Oxygenta Pharmaceutical Ltd stock?

The Earnings Per Share (EPS) of Oxygenta Pharmaceutical Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Oxygenta Pharmaceutical Ltd EPS calculated?

The EPS of Oxygenta Pharmaceutical Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Oxygenta Pharmaceutical Ltd report its EPS?

Oxygenta Pharmaceutical Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Oxygenta Pharmaceutical Ltd EPS?

Factors that influence the EPS of Oxygenta Pharmaceutical Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Oxygenta Pharmaceutical Ltd EPS growth indicate future performance?

Yes, consistent growth in Oxygenta Pharmaceutical Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*